Last reviewed · How we verify

NCT03980158

Change in Tongue Strength and Fatigue After Upper Airway Stimulation Therapy

Completed Last updated 10 June 2019
What this trial tests

trial in Obstructive Sleep Apnea of Adult in 103 participants. Completed in 16 November 2018.

Timeline
1 March 2018
Primary endpoint
16 November 2018
16 November 2018

Quick facts

Lead sponsorTechnical University of Munich
StatusCompleted
Study typeOBSERVATIONAL
Enrollment103
Start date1 March 2018
Primary completion16 November 2018
Estimated completion16 November 2018
Sites1 location across Germany

Conditions studied

Sponsor

Technical University of Munich

Who can join

18 and older, any sex, with Obstructive Sleep Apnea of Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Upper airway stimulation (UAS) is an effective surgical alternative for patients with obstructive sleep apnea (OSA) who fail continuous positive airway pressure (CPAP) therapy. This stimulation could lead to alterations in tongue strength and fatigability which could alter treatment outcome. The aim of the study is to investigate if UAS alters tongue strength and fatigability.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Hypoglossal nerve stimulation therapy does not alter tongue protrusion strength and fatigability in obstructive sleep apnea.
    Wirth M, Unterhuber D, von Meyer F, Hofauer B, et al · · 2020 · cited 9× · PMID 31992396 · DOI 10.5664/jcsm.8184

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea of Adult

Currently open trials in the same condition.

Other Technical University of Munich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03980158.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing